Related Experiment Video

Updated: Aug 24, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Glucose 6 phosphate dehydrogenase (G6PD) deficiency is a possible risk factor for the development of preeclampsia

N H Abdulhadi1

  • 1Department of Laboratory Sciences, College of Health Sciences, P.O. Box 418, Gizan, Saudi Arabia. nasruddina@hotmail.com

Medical Hypotheses
|April 15, 2004
PubMed

Insights

Pregnant women with glucose 6 phosphate dehydrogenase (G6PD) deficiency may face a higher risk of preeclampsia due to reduced antioxidant protection. This deficiency impairs glutathione production, increasing susceptibility to lipid peroxidation and potential obstetric complications.

Area of Science:

  • Obstetrics and Gynecology
  • Biochemistry
  • Genetics

Background:

  • Preeclampsia pathogenesis involves lipid peroxidation of syncytiotrophoblast plasma membranes (SPMs).
  • Antioxidant molecule production is crucial for protecting SPMs from oxidative damage.
  • Reduced glutathione (GSH) is a key antioxidant protecting SPMs.

Purpose of the Study:

  • To investigate the hypothesis that pregnant women with glucose 6 phosphate dehydrogenase (G6PD) deficiency have an increased risk of preeclampsia.
  • To explore the link between G6PD deficiency, GSH levels, and SPM integrity in preeclampsia.

Main Methods:

  • The study hypothesizes a correlation based on biochemical pathways.
  • Analysis of the pentose phosphate pathway's role in GSH production.
  • Review of existing literature on G6PD deficiency and preeclampsia incidence.

Main Results:

  • G6PD deficiency leads to diminished production of reduced glutathione (GSH).
  • Lower GSH levels compromise the protection of SPMs against lipid peroxidation.
  • This biochemical vulnerability is proposed to increase preeclampsia risk.

Conclusions:

  • G6PD deficiency is a potential risk factor for preeclampsia development.
  • Impaired antioxidant defense mechanisms in G6PD-deficient individuals may contribute to obstetric morbidity.
  • Further research is warranted to confirm the clinical association between G6PD deficiency and preeclampsia.

More Related Videos

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...